# Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART)

> **NCT06922240** · PHASE3 · RECRUITING · sponsor: **Suqiao Yang** · enrollment: 68 (estimated)

## Conditions studied

- Chronic Thromboembolic Pulmonary Hypertension

## Interventions

- **DRUG:** Riociguat
- **DRUG:** Routine Treatment

## Key facts

- **NCT ID:** NCT06922240
- **Lead sponsor:** Suqiao Yang
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-21
- **Primary completion:** 2026-10-30
- **Final completion:** 2027-10-31
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2025-04-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06922240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06922240, "Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06922240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*